1. 1) This paper is part XXIII of “Pharmaceutical Evaluation of Hollow-Type Suppositories,” Part XXII: Watanabe Y., Mizufune Y., Kuboyama A., Kiriyama M., Utoguchi N., Matsumoto M., Biol. Pharm. Bull., 19, 1187—1190 (1998).
2. 2) This study was presented, in part, at the Millennial World Congress of Pharmaceutical Sciences held in San Francisco, U.S.A., April, 2000.
3. The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit.
4. 4) The United States Pharmacopeial Convention, Inc. (ed.), “USP DI, 21st ed.,” Rand McNally, Taunton, MA, U.S.A., 2001, pp. 872—875.
5. 5) “USP24-NF19,” The United States Pharmacopeial Convention, Inc., Rockville, MD, U.S.A., 2000, pp. 786—787.